Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience

详细信息    查看全文

• 作者：Emilia Montagna¹ ; ^{emilia.montagna@ieo.it" class="auth_mail" title="E-mail the corresponding author} ; Vincenzo Bagnardi² ; ³ ; Nicole Rotmensz³ ; Giuseppe Viale⁴ ; ⁵ ; Giuseppe Cancello¹ ; Antonella Palazzo¹ ; Viviana Galimberti⁶ ; Paolo Veronesi⁶ ; Alberto Luini⁶ ; Mauro G. Mastropasqua⁴ ; Barbara Santillo³ ; Aron Goldhirsch⁷ ; Marco Colleoni¹
• 关键词：Luminal ; Position ; Subtypes ; Triple negative ; Tumor
• 刊名：Clinical Breast Cancer
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：15
• 期：6
• 页码：440-447
• 全文大小：1183 K

文摘

No analyses have investigated the prognostic role of medial presentation in breast cancer patients on disease-free survival (DFS) and overall survival according to immunohistochemically-defined subtypes.

Patients and Methods

We collected information from the institutional clinical database on consecutive breast cancer patients who underwent conservative surgery at the European Institute of Oncology, Milan, Italy, between 1994 and 2008. We compared the outcomes of patients with medial breast cancer with those of patients with nonmedial tumors observed at the institution during the same period.

Results

Among 7369 evaluable patients, 2254 (24%) had their primary tumors in medial quadrants and 7015 (76%) in other areas. Five-year DFS was 84.7% and 86.6% (P = .008) in patients with medial and nonmedial disease, respectively. In multivariate analysis, medial location was correlated with greater risk of recurrence (hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.11-1.35; P < .0001) and death (HR, 1.27; 95% CI, 1.09-1.49; P = .0028).

Conclusion

Medial presentation is an adverse prognostic factor for breast cancer patients.